SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PROLOR Biotech, Inc. - PBTH

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of
                   Investors of PROLOR Biotech, Inc. - PBTH

PR Newswire

NEW YORK, April 24, 2013

NEW YORK, April 24, 2013 /PRNewswire/ --Pomerantz Grossman Hufford Dahlstrom
& Gross LLP is investigating claims on behalf of investors of PROLOR Biotech,
Inc. ("PROLOR" or the "Company") (NYSE: PBTH) (ISIN: US74344F1066) (CUSIP:
74344F106) concerning the proposed acquisition of PROLOR Biotech, Inc. by OPKO
Health, Inc. in a transaction valued at approximately $480 million.

The investigation concerns whether the PROLOR directors are breaching their
fiduciary duties by failing to adequately shop the Company and maximize
shareholder value. Under the terms of the agreement, PROLOR shareholders will
be entitled to receive 0.9951 shares of OPKO Health, Inc. common stock, or a
price of $7.00 per share for each share of PROLOR common stock. However, at
least one analyst has set a target price of $8.00 per share.

PROLOR shareholders seeking more information about this acquisition are
advised to contact Robert Willoughby at rswilloughby@pomlaw.com or
212-661-1100 or 888-476-6529, ext. 237.

The firm is also investigating actions on behalf of shareholders for the
following companies: Arbitron Inc., Net1 Ueps Technologies, Inc., Universal
Technical Institute, Inc., Telanetix, Inc., Somerset Hills Bancorp, BioClinica
Inc., and Gardner Denver, Inc.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego,
is acknowledged as one of the premier firms in the areas of corporate,
securities, and antitrust class litigation. Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the Pomerantz Firm
pioneered the field of securities class actions. Today, more than 75 years
later, the Pomerantz Firm continues in the tradition he established, fighting
for the rights of the victims of securities fraud, breaches of fiduciary duty,
and corporate misconduct. The Firm has recovered numerous multimillion-dollar
damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.

SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP

Website: http://www.pomerantzlaw.com
Contact: Robert Willoughby, Pomerantz Grossman Hufford Dahlstrom & Gross LLP,
212-661-1100 ext. 237, rswilloughby@pomlaw.com
 
Press spacebar to pause and continue. Press esc to stop.